Myosotis Combination 9234
NDC 63083-9234, Myosotis Combination, liquid, from Professional Complementary Health Formulas.
- Product NDC
- 63083-9234
- Status
- Listed
- Labeler
- Professional Complementary Health Formulas
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63083-9234 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SCROPHULARIA NODOSA WHOLE3 [hp_X]/29.5mL
- TEUCRIUM SCORODONIA FLOWERING TOP3 [hp_X]/29.5mL
- VERONICA BECCABUNGA WHOLE3 [hp_X]/29.5mL
- EQUISETUM HYEMALE WHOLE4 [hp_X]/29.5mL
- FUMARIA OFFICINALIS FLOWERING TOP4 [hp_X]/29.5mL
- GERANIUM ROBERTIANUM WHOLE4 [hp_X]/29.5mL
- MYOSOTIS ARVENSIS WHOLE4 [hp_X]/29.5mL
- NASTURTIUM OFFICINALE4 [hp_X]/29.5mL
- SODIUM SULFATE4 [hp_X]/29.5mL
- PINUS SYLVESTRIS LEAFY TWIG4 [hp_X]/29.5mL
- GENTIANA LUTEA ROOT5 [hp_X]/29.5mL
- ENGLISH WALNUT6 [hp_X]/29.5mL
- SMILAX ORNATA ROOT6 [hp_X]/29.5mL
- ARANEUS DIADEMATUS9 [hp_X]/29.5mL
- ANHYDROUS DIBASIC CALCIUM PHOSPHATE12 [hp_X]/29.5mL
- FERROUS IODIDE12 [hp_X]/29.5mL
- BOS TAURUS LYMPH VESSEL12 [hp_X]/29.5mL
- THYROID, UNSPECIFIED12 [hp_X]/29.5mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Nut Proteins [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63083-9234-1 | 63083923401 | 29.5 mL in 1 BOTTLE, DROPPER (63083-9234-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63083-9234 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63083-9234 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63083-9234. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.